Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH.
Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH.
Nanomedicine. 2020 Aug;28:102205. doi: 10.1016/j.nano.2020.102205. Epub 2020 Apr 17.
Choroidal neovascularization (CNV) is the abnormal growth of blood vessels that sprout from the choroid vasculature and grow beneath and into the retina. The newly formed blood vessels in CNV often leak blood and fluid which deteriorates vision over time, eventually leading to blindness. In the present study, we examined the efficacy of intravenously injected gold nanoparticles in the laser-induced CNV animal model. Using optical coherence tomography (OCT) and fluorescein angiography, we evaluated CNV lesions longitudinally, over a period of 21 days, with and without nanoparticle treatment. Intravenously injected low concentration of bare gold nanoparticles showed significant anti-angiogenic properties by suppressing CNV development and progression. The treatment group showed significantly decreased fluorescein leakage at the CNV site compared to vehicle injected control mice. OCT assisted CNV volume measurement at all time points showed a significant reduction in lesion size in the treatment group compared with controls.
脉络膜新生血管(CNV)是脉络膜血管中异常生长的血管,从脉络膜血管中发芽并生长到视网膜下方和内部。CNV 中新形成的血管常常会漏出血液和液体,随着时间的推移会损害视力,最终导致失明。在本研究中,我们检查了静脉内注射金纳米粒子在激光诱导的 CNV 动物模型中的疗效。使用光学相干断层扫描(OCT)和荧光素血管造影术,我们在 21 天的时间内对 CNV 病变进行了纵向评估,包括有无纳米粒子治疗。静脉内注射低浓度的裸金纳米粒子通过抑制 CNV 的发展和进展显示出显著的抗血管生成特性。与注射载体的对照组小鼠相比,治疗组在 CNV 部位的荧光素渗漏明显减少。OCT 辅助的 CNV 体积测量在所有时间点均显示出治疗组与对照组相比病变大小显著减小。